HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coty

This article was originally published in The Rose Sheet

Executive Summary

Adidas toiletries line represents entry into antiperspirant/deodorant category, licensee Coty says. Line is "logical" extension of Adidas Moves men's fragrance, which is based on athleticism and performance and bowed in the U.S. in 1999 ("The Rose Sheet" May 31, 1999, p. 3). Products, which also include aftershave, will be distributed heavily in food retail outlets where 40% of antiperspirant sales typically are made, rather than through Coty's partnership with Sears, the company says. Beginning in December, antiperspirant and deodorant will retail for $2.43 and aftershave will cost $5.99 in three scents: Team (energizing citrus), Sport (cool spice) and Dynamic (outdoor fresh)

You may also be interested in...



Coty Healing Garden Ad Spend Quadrupling To Support "Treatment" Scent

Coty will increase advertising support for its Healing Garden aromatherapy specialty bath line four fold within the next 12 months to boost the "impact" of the brand, U.S. President Eric Thoreux said.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008697

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel